PedAM
Pediatric Disease Annotations & Medicines
| Disease | cystic fibrosis |
| Phenotype | |lung disease |
| Sentences | 65 |
| PubMedID- 22035707 | We describe the successful use of ambulatory single-venous vv ecmo as a bridge to bilateral lung transplantation in 4 patients with end-stage lung disease due to cystic fibrosis who developed acute hypercapnic respiratory failure. |
| PubMedID- 25929952 | Percentages of airway cxcr4(+) granulocytes correlated with lung disease severity in patients with cystic fibrosis.these studies demonstrate that chronic fungal colonisation with a. |
| PubMedID- 23076917 | Authors' conclusions: there is currently no evidence to support the use of cftr gene transfer reagents as a treatment for lung disease in people with cystic fibrosis. |
| PubMedID- 26022611 | Background: to assess the severity of lung disease in cystic fibrosis (cf), scoring systems based on chest radiographs (cxrs), ct and mri have been used extensively, although primarily in research settings rather than for clinical purposes. |
| PubMedID- 23272037 | It is known that low doses of dexamethasone slow the progression of lung disease in patients with cystic fibrosis through its role in reducing the inflammation associated with the bacterial infection [26]. |
| PubMedID- 21382942 | cystic fibrosis and survival in patients with advanced lung disease. |
| PubMedID- 25070399 | We describe the case of a young patient with end-stage lung disease due to of cystic fibrosis and liver cirrhosis who needed combined lung-liver transplantation. |
| PubMedID- 22497648 | We report a 29 year old male cystic fibrosis patient with end stage lung disease and normal renal function who underwent a sequential double lung transplant. |
| PubMedID- 25725986 | Background: although recent studies have begun to elucidate how airway microbial community structure relates to lung disease in cystic fibrosis (cf), microbial community activity and the host's response to changes in this activity are poorly understood. |
| PubMedID- 22538801 | Rationale: airways obstruction and lung volume restriction, major features of lung disease in cystic fibrosis (cf), may regress independently, causing dysanapsis between these parameters. |
| PubMedID- 22431492 | Background: hypoxemia during sleep is a common finding in cystic fibrosis (cf) patients with more advanced lung disease. |
| PubMedID- 22162514 | Regional differences in the evolution of lung disease in children with cystic fibrosis. |
| PubMedID- 22608703 | Background: it is not known whether antibiotic therapy for lung disease in cystic fibrosis (cf) has an influence on circulating polymorphonuclear neutrophil (pmn) function and apoptosis. |
| PubMedID- 24671311 | Polysomnographic differences associated with pulmonary hypertension in patients with advanced lung disease due to cystic fibrosis. |
| PubMedID- 25963404 | Background: cystic fibrosis (cf) leads to advanced lung disease despite aggressive care. |
Page: 1 2